At UMB, our mission is to improve the human condition through education, research, and innovation. As faculty and staff, you play a vital role in shaping a brighter future by fostering knowledge, advancing discovery, and supporting a thriving community.

Happening at UMB

The UMB Pulse Podcast

From ‘Food Noise’ to Stimulant Cravings — A New GLP-1 Trial at UMB

In the latest episode of “The UMB Pulse” podcast, University of Maryland School of Medicine (UMSOM) associate professor Sarah M. Kattakuzhy, MD, talks about her research exploring whether semaglutide — a GLP-1 medication widely used for diabetes and weight management — could help reduce cravings and improve outcomes for people with stimulant use disorder. Kattakuzhy, who is also co-director of the Kahlert Institute for Addiction Medicine at UMSOM, describes how the study is evaluating the safety and tolerability of semaglutide in people with cocaine use disorder, including participants with and without HIV, while also tracking secondary outcomes such as changes in drug use and cravings.

Listen to ‘The UMB Pulse’

Events